ASX:PKYSoftware & ServicesApplication Software
Pathkey.AI Ltd
$0.060
+$0.005 (+9.09%)
Day Range
$0.050 – $0.062
52 Week Range
$0.013 – $0.071
Volume
10.96M
Avg Volume (10D)
3.49M
Market Cap
$36.42M
Price Chart
Market Statistics
Open$0.055
Previous Close$0.055
Day High$0.062
Day Low$0.050
52 Week High$0.071
52 Week Low$0.013
Valuation
Market Cap36.42M
Shares Outstanding607.08M
Price to Book39.15
Trading Activity
Volume10.96M
Value Traded637.56K
Bid$0.058 × 262,187
Ask$0.061 × 250,000
Performance
1 Day7.41%
5 Day52.63%
13 Week176.19%
52 Week193.45%
YTD262.50%
Technical Indicators
RSI (14)71.46
50-Day SMA$0.040
200-Day SMA$0.026
Latest News
Technology
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
Technology
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
Technology
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]